id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2006-P-0033-0055,FDA,FDA-2006-P-0033,Food Labeling; Health Claim; Phytosterols and Risk of Coronary Heart Disease; Reopening of the Comment Period,Proposed Rule,Notice of Proposed Rulemaking (NPRM),2011-08-11T04:00:00Z,2011,8,2011-08-11T04:00:00Z,2011-10-26T03:59:59Z,2011-08-11T14:47:58Z,2011-20406,0,0,0900006480eddb34
FDA-2006-P-0033-0051,FDA,FDA-2006-P-0033,"Acknowledgement Letter to Botanical Laboratories, Inc. (Kleinfeld Kaplan and Becker, LLP)",Other,ACK-Acknowledgement Letter,2011-03-24T04:00:00Z,2011,3,2011-03-24T04:00:00Z,,2013-07-27T23:48:11Z,,0,0,0900006480c0df47
FDA-2006-P-0033-0050,FDA,FDA-2006-P-0033,"Botanical Laboratories, Inc. (Kleinfeld Kaplan and Becker, LLP) - Petition for Stay",Other,PSA-Petition for Stay,2011-03-24T04:00:00Z,2011,3,2011-03-24T04:00:00Z,,2013-08-11T01:40:39Z,,0,0,0900006480c1056b
FDA-2006-P-0033-0049,FDA,FDA-2006-P-0033,"Acknowledgement Letter to Pharmavite LLC (Kleinfeld, Kaplan and Becker, LLP)",Other,ACK-Acknowledgement Letter,2011-03-04T05:00:00Z,2011,3,2011-03-04T05:00:00Z,,2013-07-27T23:46:13Z,,0,0,0900006480bfae2d
FDA-2006-P-0033-0048,FDA,FDA-2006-P-0033,"Exhibit D - ""Kevin C. Maki, Ph.D. - Curriculum Vitae""  [Pharmavite LLC (Kleinfeld, Kaplan and Becker, LLP) - Citizen Petition] re FDA-2006-P-0033-0045",Supporting & Related Material,CP-Citizen Petition (Supporting & Related Materials),2011-03-04T05:00:00Z,2011,3,,,2011-03-04T22:58:44Z,,0,0,0900006480c0084e
FDA-2006-P-0033-0047,FDA,FDA-2006-P-0033,"Exhibit C - ""Maki, et al., A Plant Sterol/Stanol Supplement in Tablet Form Lowers LDL and Non-HDL Cholesterol in Men and Woman with Primary Hypercholesterolemia (Poster)"" - [Pharmavite LLC (Kleinfeld, Kaplan and Becker, LLP) - Citizen Petition] re FDA-2006-P-0033-0045",Supporting & Related Material,CP-Citizen Petition (Supporting & Related Materials),2011-03-04T05:00:00Z,2011,3,,,2011-03-04T22:59:53Z,,0,0,0900006480c0084c
FDA-2006-P-0033-0045,FDA,FDA-2006-P-0033,"Pharmavite LLC (Kleinfeld, Kaplan and Becker, LLP) - Citizen Petition",Other,CP-Citizen Petition,2011-03-04T05:00:00Z,2011,3,2011-03-04T05:00:00Z,,2024-11-07T22:28:35Z,,1,0,0900006480bfae2a
FDA-2006-P-0033-0046,FDA,FDA-2006-P-0033,"Exhibit A - ""Container and Carton Label for Nature Made® Cholestoff®"" - [Pharmavite LLC (Kleinfeld, Kaplan and Becker, LLP) - Citizen Petition] re FDA-2006-P-0033-0045",Supporting & Related Material,CP-Citizen Petition (Supporting & Related Materials),2011-03-04T05:00:00Z,2011,3,,,2011-03-04T22:58:40Z,,0,0,0900006480c0084a
FDA-2006-P-0033-0038,FDA,FDA-2006-P-0033,"Exhibit D - ""Kevin C. Maki, Ph.D. - Curriculum Vitae"" - [Pharmavite LLC - Petition for Stay of Action] re FDA-2006-P-0033-0035",Supporting & Related Material,PSA- Petition for Stay (Supporting and Related Material),2011-03-02T05:00:00Z,2011,3,,,2011-03-02T20:22:32Z,,0,0,0900006480bfd1d8
FDA-2006-P-0033-0035,FDA,FDA-2006-P-0033,"Pharmavite LLC (Kleinfeld, Kaplan and Becker, LLP) - Petition for Stay of Action",Other,PSA-Petition for Stay,2011-03-02T05:00:00Z,2011,3,2011-03-02T05:00:00Z,,2024-11-07T22:28:44Z,,1,0,0900006480bfa44c
FDA-2006-P-0033-0037,FDA,FDA-2006-P-0033,"Exhibit C - ""Maki, et al., A Plant Sterol/Stanol Supplement in Tablet Form Lowers LDL and Non-HDL Cholesterol in Men and Woman with Primary Hypercholesterolemia (Poster)"" - [Pharmavite LLC - Petition for Stay of Action] re FDA-2006-P-0033-0035",Supporting & Related Material,PSA- Petition for Stay (Supporting and Related Material),2011-03-02T05:00:00Z,2011,3,,,2011-03-02T20:22:30Z,,0,0,0900006480bfa463
FDA-2006-P-0033-0036,FDA,FDA-2006-P-0033,"Exhibit A - ""Container and Carton Label for Nature Made® Cholestoff®"" - [Pharmavite LLC - Petition for Stay of Action] re FDA-2006-P-0033-0035",Supporting & Related Material,PSA- Petition for Stay (Supporting and Related Material),2011-03-02T05:00:00Z,2011,3,,,2011-03-02T20:22:28Z,,0,0,0900006480bfa45f
FDA-2006-P-0033-0039,FDA,FDA-2006-P-0033,"Acknowledgement Letter to Pharmavite LLC (Kleinfeld, Kaplan and Becker, LLP)",Other,ACK-Acknowledgement Letter,2011-03-02T05:00:00Z,2011,3,2011-03-02T05:00:00Z,,2013-07-27T23:46:08Z,,0,0,0900006480bfa45b
FDA-2006-P-0033-0031,FDA,FDA-2006-P-0033,"Attachment 5 - ""On the Authorisation of Certain Health Claims Made on Food and Referring to the Reduction of Disease Risk an to Children's Development and Health "" - [Innoceutics bvba-llC University of Ghent - Comment] re FDA-2006-P-0033-0029",Supporting & Related Material,C-Comment (Supporting and Related Material),2011-02-28T05:00:00Z,2011,2,,,2011-02-28T22:12:13Z,,0,0,0900006480bfadfd
FDA-2006-P-0033-0030,FDA,FDA-2006-P-0033,"Attachment 4 - ""On Nutrition and Health Claims Made on Food"" - [Innoceutics bvba-llC University of Ghent - Comment] re FDA-2006-P-0033-0029",Supporting & Related Material,C-Comment (Supporting and Related Material),2011-02-28T05:00:00Z,2011,2,,,2011-02-28T22:12:12Z,,0,0,0900006480bfadfc
FDA-2006-P-0033-0032,FDA,FDA-2006-P-0033,"Attachment 6 - ""Amending Regulation (EC) No. 983/2009 on the Authorisation and Refusal of Authorisation of Certain Health Claims Made on Food and Referring to the Reduction of Disease Risk and to Children's Development and Health"" - [Innoceutics bvba-llC University of Ghent - Comment] re FDA-2006-P-0033-0029",Supporting & Related Material,C-Comment (Supporting and Related Material),2011-02-28T05:00:00Z,2011,2,,,2011-02-28T22:12:15Z,,0,0,0900006480bfadfe
FDA-2006-P-0033-0033,FDA,FDA-2006-P-0033,"Unilever United States, Inc - Supplement",Other,SUP-Supplement,2011-02-28T05:00:00Z,2011,2,2011-02-28T05:00:00Z,,2011-02-28T22:19:20Z,,0,0,090000648044211c
FDA-2006-P-0033-0028,FDA,FDA-2006-P-0033,"Reference - ""Letter of Enforcement Discretion From FDA to Cargill Health & Food Technologies, February 14, 2003"" - [Extension of Enforcement Discretion: Health Claim, Phytosterols and Risk of Coronary Heart Disease] re FDA-2006-P-0033-0027",Supporting & Related Material,BKG-Background Material,2011-02-18T05:00:00Z,2011,2,,,2011-02-28T20:53:35Z,,0,0,0900006480bf1444
FDA-2006-P-0033-0027,FDA,FDA-2006-P-0033,"Health Claim, Phytosterols and Risk of Coronary Heart Disease",Proposed Rule,NEC-Notice of Extension,2011-02-18T05:00:00Z,2011,2,2011-02-18T05:00:00Z,2011-04-20T03:59:59Z,2011-02-28T21:08:27Z,2011-3678,0,0,0900006480bf2522
FDA-2006-P-0033-0025,FDA,FDA-2006-P-0033,Venable LLP - Request for Extension Comment Due Date,Other,EXT-Request for Extension Comment Due Date,2011-02-15T05:00:00Z,2011,2,2011-02-15T05:00:00Z,,2013-07-27T23:45:23Z,,0,0,0900006480befd95
FDA-2006-P-0033-0022,FDA,FDA-2006-P-0033,"Acknowledgement Letter to Fommer Lawrence & Haug LLP (Pharmachem Laboratories, Inc.)",Other,ACK-Acknowledgement Letter,2011-02-08T05:00:00Z,2011,2,2011-02-08T05:00:00Z,,2011-02-08T12:58:21Z,,0,0,0900006480bd7030
FDA-2006-P-0033-0021,FDA,FDA-2006-P-0033,"Fommer Lawrence & Haug LLP (Pharmachem Laboratories, Inc.) - Petition for Stay of Action",Other,PSA-Petition for Stay,2011-02-08T05:00:00Z,2011,2,2011-02-08T05:00:00Z,,2011-02-08T12:58:02Z,,0,0,0900006480bd702d
FDA-2006-P-0033-0018,FDA,FDA-2006-P-0033,Acknowledgement Letter to Covington & Burling (Cargill Inc.),Other,ACK-Acknowledgement Letter,2011-01-10T05:00:00Z,2011,1,2011-01-10T05:00:00Z,,2011-01-10T22:37:53Z,,0,0,0900006480bc861f
FDA-2006-P-0033-0017,FDA,FDA-2006-P-0033,Covington & Burling (Cargill Inc.) - Petition for Stay of Action,Other,PSA-Petition for Stay,2011-01-10T05:00:00Z,2011,1,2011-01-10T05:00:00Z,,2024-11-12T04:58:58Z,,1,0,0900006480bc861d
FDA-2006-P-0033-0016,FDA,FDA-2006-P-0033,Council for Responsible Nutrition - Letter,Other,LET-Letter,2011-01-10T05:00:00Z,2011,1,2011-01-10T05:00:00Z,,2013-07-27T23:42:03Z,,0,0,0900006480bc861a